Market Overview:
The global newborn screening software market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of genetic disorders, technological advancements in newborn screening software, and rising government initiatives for early diagnosis and treatment of genetic disorders. Based on type, the global newborn screening software market is segmented into tandem mass spectrometry, pulse oximetry, enzyme based assays, DNA assays, and electrophoresis. Tandem mass spectrometry held the largest share of the global newborn screening software market in 2017 owing to its high accuracy and sensitivity. Based on application, the global newborn screening software market is segmented into control and monitoring; overall management of Newborn Screening Program (NSP); data management; and decision support.
Product Definition:
Newborn Screening Software is a computer-based tool used to help healthcare professionals identify and diagnose medical conditions in newborns. It is important because it can help detect medical conditions early, which can improve the chances of successful treatment.
Tandem Mass Spectrometry:
Tandem mass spectrometry is a technique that involves the separation of an unknown compound or substance in mixtures by its molecular weight, and then analyzing the separated peak for further information. The tandem mass spectrum is obtained by introducing a second stream of liquid with sample solution and waiting until all the molecules have passed through the filter before measuring the concentration. This process allows measurement of compounds at higher concentrations than are possible using single-stream techniques.
Pulse Oximetry:
Pulse oximetry is a method to measure the oxygen saturation level in blood using an earlobe or finger. The normal range for pulse oximeters is 90-100% (SpO2). If the SpO2 levels get below 85%, then medical help needs to be taken immediately.
Application Insights:
The overall management of newborn screening program segment dominated the global market in 2017. This is attributed to its critical nature and the need for effective implementation of policies related to it. The control and monitoring segment is expected to witness lucrative growth over the forecast period due to an increase in awareness about early detection of conditions, such as Down syndrome, that require immediate medical attention.
DNA analysis for condition such as congenital heart disease or chromosomal abnormalities requires a high level of accuracy which can be achieved through automated equipment. Thus, companies are focusing on developing advanced software solutions that offer ease-of-use while ensuring accurate results with lower turnaround time. In addition, these solutions should also be able to integrate with other systems used across healthcare facilities such as electronic health records (EHRs) and laboratory information systems (LIS).
Regional Analysis:
North America dominated the global newborn screening software market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and government support for new born screening programs. The U.S., which is at the forefront of this region, has a strong network of public health laboratories that perform newborn screening throughout various states under federal guidelines.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase in birth rates and declining infant mortality rate coupled with rising awareness about newborn care practices among parents in emerging economies such as India and China. Furthermore, increasing disposable income levels are anticipated to boost demand for these products over the next eight years due to rise adoption by governments across countries such as India & China for effective management & monitoring along with data collection purposes associated with Newborn Screening Program (NSP).
Growth Factors:
- Increasing incidence of newborn diseases: The global incidence of newborn diseases is increasing due to various factors such as changing lifestyle, environmental pollution, and others. This is expected to drive the demand for newborn screening software in the coming years.
- Growing awareness about benefits of early diagnosis: There is a growing awareness among parents and healthcare professionals about the benefits of early diagnosis through newborn screening tests. This is expected to boost the demand for such software in the near future.
- Technological advancements: The development of new technologies in neonatal screening has led to introduction of novel methods for detecting various disorders at an early stage. This is anticipated to fuel the growth of this market in forthcoming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Newborn Screening Software Market Research Report
By Type
Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, Electrophoresis
By Application
Control and Monitoring, Overall Management of Newborn Screening Program, Data Management, Decision Support
By Companies
PerkinElmer, Siemens, Bio-Rad, OZ Systems, NeoScreen, Astoria Pacific, Masimo, Northgate, SCIEX, OMNI-Lab NBS, Shimadzu
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Newborn Screening Software Market Report Segments:
The global Newborn Screening Software market is segmented on the basis of:
Types
Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, Electrophoresis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Control and Monitoring, Overall Management of Newborn Screening Program, Data Management, Decision Support
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PerkinElmer
- Siemens
- Bio-Rad
- OZ Systems
- NeoScreen
- Astoria Pacific
- Masimo
- Northgate
- SCIEX
- OMNI-Lab NBS
- Shimadzu
Highlights of The Newborn Screening Software Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tandem Mass Spectrometry
- Pulse Oximetry
- Enzyme Based Assays
- DNA Assays
- Electrophoresis
- By Application:
- Control and Monitoring
- Overall Management of Newborn Screening Program
- Data Management
- Decision Support
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Newborn Screening Software Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Newborn screening software is a computer program that helps health care providers screen for certain birth defects in newborns.
Some of the key players operating in the newborn screening software market are PerkinElmer, Siemens, Bio-Rad, OZ Systems, NeoScreen, Astoria Pacific, Masimo, Northgate, SCIEX, OMNI-Lab NBS, Shimadzu.
The newborn screening software market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Newborn Screening Software Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Newborn Screening Software Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Newborn Screening Software Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Newborn Screening Software Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Newborn Screening Software Market Size & Forecast, 2018-2028
4.5.1 Newborn Screening Software Market Size and Y-o-Y Growth
4.5.2 Newborn Screening Software Market Absolute $ Opportunity
Chapter 5 Global Newborn Screening Software Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Newborn Screening Software Market Size Forecast by Type
5.2.1 Tandem Mass Spectrometry
5.2.2 Pulse Oximetry
5.2.3 Enzyme Based Assays
5.2.4 DNA Assays
5.2.5 Electrophoresis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Newborn Screening Software Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Newborn Screening Software Market Size Forecast by Applications
6.2.1 Control and Monitoring
6.2.2 Overall Management of Newborn Screening Program
6.2.3 Data Management
6.2.4 Decision Support
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Newborn Screening Software Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Newborn Screening Software Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Newborn Screening Software Analysis and Forecast
9.1 Introduction
9.2 North America Newborn Screening Software Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Newborn Screening Software Market Size Forecast by Type
9.6.1 Tandem Mass Spectrometry
9.6.2 Pulse Oximetry
9.6.3 Enzyme Based Assays
9.6.4 DNA Assays
9.6.5 Electrophoresis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Newborn Screening Software Market Size Forecast by Applications
9.10.1 Control and Monitoring
9.10.2 Overall Management of Newborn Screening Program
9.10.3 Data Management
9.10.4 Decision Support
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Newborn Screening Software Analysis and Forecast
10.1 Introduction
10.2 Europe Newborn Screening Software Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Newborn Screening Software Market Size Forecast by Type
10.6.1 Tandem Mass Spectrometry
10.6.2 Pulse Oximetry
10.6.3 Enzyme Based Assays
10.6.4 DNA Assays
10.6.5 Electrophoresis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Newborn Screening Software Market Size Forecast by Applications
10.10.1 Control and Monitoring
10.10.2 Overall Management of Newborn Screening Program
10.10.3 Data Management
10.10.4 Decision Support
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Newborn Screening Software Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Newborn Screening Software Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Newborn Screening Software Market Size Forecast by Type
11.6.1 Tandem Mass Spectrometry
11.6.2 Pulse Oximetry
11.6.3 Enzyme Based Assays
11.6.4 DNA Assays
11.6.5 Electrophoresis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Newborn Screening Software Market Size Forecast by Applications
11.10.1 Control and Monitoring
11.10.2 Overall Management of Newborn Screening Program
11.10.3 Data Management
11.10.4 Decision Support
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Newborn Screening Software Analysis and Forecast
12.1 Introduction
12.2 Latin America Newborn Screening Software Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Newborn Screening Software Market Size Forecast by Type
12.6.1 Tandem Mass Spectrometry
12.6.2 Pulse Oximetry
12.6.3 Enzyme Based Assays
12.6.4 DNA Assays
12.6.5 Electrophoresis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Newborn Screening Software Market Size Forecast by Applications
12.10.1 Control and Monitoring
12.10.2 Overall Management of Newborn Screening Program
12.10.3 Data Management
12.10.4 Decision Support
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Newborn Screening Software Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Newborn Screening Software Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Newborn Screening Software Market Size Forecast by Type
13.6.1 Tandem Mass Spectrometry
13.6.2 Pulse Oximetry
13.6.3 Enzyme Based Assays
13.6.4 DNA Assays
13.6.5 Electrophoresis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Newborn Screening Software Market Size Forecast by Applications
13.10.1 Control and Monitoring
13.10.2 Overall Management of Newborn Screening Program
13.10.3 Data Management
13.10.4 Decision Support
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Newborn Screening Software Market: Competitive Dashboard
14.2 Global Newborn Screening Software Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PerkinElmer
14.3.2 Siemens
14.3.3 Bio-Rad
14.3.4 OZ Systems
14.3.5 NeoScreen
14.3.6 Astoria Pacific
14.3.7 Masimo
14.3.8 Northgate
14.3.9 SCIEX
14.3.10 OMNI-Lab NBS
14.3.11 Shimadzu
